China Pediatric Pharmaceuticals (CPDU) Growth Rates Comparisons to Healthcare Facilities Industry, Sector, Market. Sales, Income, EPS
CSIMarket Company Name, Ticker, Customers, else..
 
China Pediatric Pharmaceuticals, Inc.  (CPDU)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare
 

China Pediatric Pharmaceuticals Growth Comparisons

Select each growth Category to receive further Information




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CPDU Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q1 MRQ) 79.17 % 14.92 % 9.82 % 3.37 %
Q / Q Revenue Growth (Q1 MRQ) 40.85 % -28.88 % -13.79 % -13.24 %
Y / Y Revenue Growth (for 12 months ending Q1 TTM) -56.69 % 44.05 % 5.12 % %
Sequential Revenue Growth (for 12 months ending Q1 TTM) 18.75 % 1.99 % 2.29 % 0.72 %
Revenue 5 Year Average Growth - 63.97 % 11.73 % 10.54 %


CPDU's Growth Comparisons in I. Quarter 2014




China Pediatric Pharmaceuticals showed respectable 79.17% year on year rise of Revenue in the first quarter 2014, comparing favorably to the 14.92% rise in the Healthcare Facilities industry, and 9.82% growth in the Healthcare sector. Above the average sales gains in the Healthcare and in the Healthcare Facilities industry, helped to elevate overall market growth to 3.37%.

Top-line grew by 40.85% from the fourth quarter. Average yearly sales growth for China Pediatric Pharmaceuticals is %, while S & P 500's average annual sales increase is 10.54% over the five years, including only Businesses with the first quarter 2014 Results.


Growth Rates of CPDU's Income in the first quarter 2014


CPDU Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q1 MRQ) - 2.85 % 14.35 % 0.64 %
Sequential Operating Income Change (Q1 MRQ) - - 70.45 % 231.26 %
Y / Y Operating Income Growth (Q1 TTM) - 3.82 % 1 % 14.32 %
Sequential Operating Income Growth (Q1 TTM) - 4.71 % 3.44 % 2.38 %
Operating Income 5 Year Avg. Change - - 3.82 % 22.03 %


Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q1 MRQ) - -37.38 % 5.25 % -17.16 %
Sequential Income from Cont. Ops. Change (Q1 MRQ) - -51.17 % 141.01 % -6.9 %
Y / Y Income from Cont. Ops. Change (Q1 TTM) - 21.87 % -5.28 % 7.25 %
Sequential Income from Cont. Ops. Change (Q1 TTM) - 5.9 % 2.36 % -4.99 %
Income from Cont. Ops. 5 Year Avg. Change - 68.26 % 1.89 % 40.7 %

CPDU Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q1 MRQ) - -57.94 % 5.81 % -1.55 %
Q / Q Net Income Growth (Q1 MRQ) - -54.56 % 24.95 % -28.34 %
Y / Y Net Income Change (Q1 TTM) - 1.9 % 12.12 % 14.15 %
Sequential Net Income Change (Q1 TTM) - 9.3 % 1.99 % -0.34 %
Net Income 5 Year Avg. Growth - 68.68 % 6.74 % 39.75 %

CPDU's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q1 MRQ) - -45.01 % 5.25 % -17.16 %
Sequential EPS from Cont. Ops. Change (Q1 MRQ) - -52.3 % 141.01 % -6.9 %
Y / Y EPS from Cont. Ops. Change (Q1 TTM) - -98 % - -
Sequential EPS from Cont. Ops. Change (Q1 TTM) - -94.67 % -91.78 % -
EPS from Cont. Ops. 5 Year Avg. Growth - 20.27 % 1.89 % 40.7 %



CPDU EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q1 MRQ) - -63.07 % 5.81 % -1.55 %
Q / Q EPS Net Growth (Q1 MRQ) - -55.62 % 24.95 % -28.34 %
Y / Y EPS Net Change (for 12 months ending Q1 TTM) - -98.05 % - 24.55 %
Sequential EPS Net Change (for 12 months ending Q1 TTM) - -89.72 % - 3.04 %
EPS Net 5 Year Avg. Change - 68.68 % 6.74 % 39.75 %



China Pediatric Pharmaceuticals reported bottom-line of $ -0.03 in the first quarter, compare to $ -0.11 in the same quarter a year ago. Healthcare Facilities industry fell by -63.07%, while Healthcare sector increased by 5.81%, and overall market declined by -1.55%.

The bottom-line grew by 40.85% from the fourth quarter. Average yearly income per share growth for China Pediatric Pharmaceuticals is %, while S & P 500's average annual income per share increase is 39.75% over the five years, including only Businesses with the first quarter 2014 earnings reports.

CPDU Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q1 MRQ) 2709.97 % 850.38 % 38.15 % 0.61 %
Sequential Free Cash Flow Change (Q1 MRQ) 465.71 % 27.18 % -48.69 % -39.58 %
Y / Y Free Cash Flow Change (Q1 TTM) - -15.54 % -0.15 % 11.71 %
Sequential Free Cash Flow Change (Q1 TTM) 301.48 % -17.85 % 3.24 % -1.33 %
Free Cash Flow 5 Year Avg. Change - 150.11 % 4.59 % -3.52 %

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q1 MRQ) 740.91 % - - -
Sequential Net Cash Flow Change (Q1 MRQ) 40.63 % 4785.61 % -63.69 % -
Y / Y Net Cash Flow Change (Q1 TTM) - - - -
Sequential Net Cash Flow Change (Q1 TTM) - 136 % 402.33 % -34.72 %
Net Cash Flow 5 Year Avg. Change - - -17.12 % -

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q1 MRQ) - 368.37 % 63.17 % 12.18 %
Sequential Capital Expenditures Change (Q1 MRQ) - 111.73 % -41.27 % -14.66 %
Y / Y Capital Expenditures Change (Q1 TTM) - 7.58 % -6.55 % 1.57 %
Sequential Capital Expenditures Change (Q1 TTM) - 5.64 % 3.24 % 2.25 %
Capital Expenditures 5 Year Avg. Change - 49.97 % 8.72 % 6.43 %

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Y/Y Annual




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.